Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience
Background: Familial hypercholesterolaemia (FH) is a co-dominantly inherited disorder of low-density lipoprotein (LDL) catabolism, causing elevated LDL-cholesterol and premature coronary artery disease (CAD). Several guidelines recommend genetic cascade screening relatives of probands (index cases)...
| Main Authors: | Bell, D., Pang, J., Burrows, S., Bates, T., van Bockxmeer, F., Hooper, A., O'Leary, Peter, Burnett, J., Watts, G. |
|---|---|
| Format: | Journal Article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/47742 |
Similar Items
Parent-child genetic testing for familial hypercholesterolaemia in an Australian context
by: Pang, J., et al.
Published: (2018)
by: Pang, J., et al.
Published: (2018)
A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology
by: Watts, G., et al.
Published: (2010)
by: Watts, G., et al.
Published: (2010)
Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
by: Ademi, Z., et al.
Published: (2014)
by: Ademi, Z., et al.
Published: (2014)
Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations
by: Watts, G., et al.
Published: (2012)
by: Watts, G., et al.
Published: (2012)
A web-based registry for familial hypercholesterolaemia
by: Napier, K., et al.
Published: (2017)
by: Napier, K., et al.
Published: (2017)
Familial hypercholesterolaemia: A model of care for Australasia
by: Watts, G., et al.
Published: (2011)
by: Watts, G., et al.
Published: (2011)
A framework for bridging the gap in the care of familial hypercholesterolaemia in the community: pragmatic and economic perspectives
by: Purchase, S., et al.
Published: (2014)
by: Purchase, S., et al.
Published: (2014)
Role of international registries in enhancing the care of familial hypercholesterolaemia
by: Hammond, E., et al.
Published: (2013)
by: Hammond, E., et al.
Published: (2013)
Patients’ Perceptions and Experiences of Familial Hypercholesterolemia, Cascade Genetic Screening and Treatment
by: Hardcastle, Sarah, et al.
Published: (2015)
by: Hardcastle, Sarah, et al.
Published: (2015)
Design of the Familial Hypercholesterolaemia Australasia Network Registry: Creating Opportunities for Greater International Collaboration
by: Bellgard, M., et al.
Published: (2017)
by: Bellgard, M., et al.
Published: (2017)
Design of the familial hypercholesterolaemia australasia network registry: Creating opportunities for greater international collaboration
by: Bellgard, M., et al.
Published: (2017)
by: Bellgard, M., et al.
Published: (2017)
Familial Hypercholesterolaemia: An Updated Overall Management
by: Mohd Kasim, Noor Alicezah, et al.
Published: (2020)
by: Mohd Kasim, Noor Alicezah, et al.
Published: (2020)
Improving identification of familial hypercholesterolaemia in primary care: Derivation and validation of the familial hypercholesterolaemia case ascertainment tool (FAMCAT)
by: Weng, Stephen F., et al.
Published: (2015)
by: Weng, Stephen F., et al.
Published: (2015)
Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales
by: Crosland, Paul, et al.
Published: (2018)
by: Crosland, Paul, et al.
Published: (2018)
Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia
by: Lázaro, P., et al.
Published: (2016)
by: Lázaro, P., et al.
Published: (2016)
Strategies for identifying familial hypercholesterolaemia in non-specialist clinical settings
by: Qureshi, Nadeem, et al.
Published: (2018)
by: Qureshi, Nadeem, et al.
Published: (2018)
Hypercholesterolaemia and vascular dementia
by: Appleton, Jason P., et al.
Published: (2017)
by: Appleton, Jason P., et al.
Published: (2017)
Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil
by: Souto, A., et al.
Published: (2018)
by: Souto, A., et al.
Published: (2018)
Feasibility of improving identification of familial hypercholesterolaemia in general practice: intervention development study
by: Qureshi, Nadeem, et al.
Published: (2016)
by: Qureshi, Nadeem, et al.
Published: (2016)
Patient and Professional Constructions of Familial Hypercholesterolaemia and Heart Disease: Testing the Limits of the Geneticisation Thesis
by: Weiner, Kate
Published: (2006)
by: Weiner, Kate
Published: (2006)
Improving identification & management of familial hypercholesterolaemia in primary care: pre- and post-intervention study
by: Weng, Stephen, et al.
Published: (2018)
by: Weng, Stephen, et al.
Published: (2018)
Ordinal reanalysis of the SHEP Trial
by: Bath, Philip M.W., et al.
Published: (2008)
by: Bath, Philip M.W., et al.
Published: (2008)
Detection of low density lipoprotein receptor gene mutations in patients with familial hypercholesterolaemia / Rafezah Razali
by: Rafezah, Razali
Published: (2011)
by: Rafezah, Razali
Published: (2011)
Communicating Familial Hypercholesterolemia Genetic Information Within Families
by: Maxwell, Susannah, et al.
Published: (2009)
by: Maxwell, Susannah, et al.
Published: (2009)
A novel mutation in exon 5 of the low density lipoprotein receptor gene in a Malay family with familial hypercholesterolaemia (FH)
by: Abdul Murad N. A.,, et al.
Published: (2013)
by: Abdul Murad N. A.,, et al.
Published: (2013)
Women's understanding and attitudes towards Down syndrome and other genetic conditions in the context of prenatal screening
by: Long, S., et al.
Published: (2017)
by: Long, S., et al.
Published: (2017)
Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)
by: Maxwell, Susannah, et al.
Published: (2011)
First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21
by: Maxwell, Susannah, et al.
Published: (2016)
by: Maxwell, Susannah, et al.
Published: (2016)
The co-ordinative practices of temporary organisations
by: Peters, Linda D., et al.
Published: (2016)
by: Peters, Linda D., et al.
Published: (2016)
Material selection based on ordinal data
by: Jahan, Ali, et al.
Published: (2010)
by: Jahan, Ali, et al.
Published: (2010)
Newborn bloodspot screening policy framework for Australia
by: O'Leary, P., et al.
Published: (2015)
by: O'Leary, P., et al.
Published: (2015)
Newborn bloodspot screening: setting the Australian national policy agenda
by: Maxwell, Susannah, et al.
Published: (2014)
by: Maxwell, Susannah, et al.
Published: (2014)
Spatial interpolation methods for interpretation of ordination diagrams
by: Mucina, Ladislav, et al.
Published: (1991)
by: Mucina, Ladislav, et al.
Published: (1991)
Prenatal screening for Down Syndrome in Australia: costs and benefits of current and novel screening strategies
by: O'Leary, Peter, et al.
Published: (2013)
by: O'Leary, Peter, et al.
Published: (2013)
Influence of gene mutations on inflammation, oxidative stress and endothelial function in patients with familial hypercholesterolaemia / Prof. Dr. Hapizah Mohd Nawawi … [et al.]
by: Mohd Nawawi, Hapizah, et al.
Published: (2010)
by: Mohd Nawawi, Hapizah, et al.
Published: (2010)
Hypocholesterolaemic and hepatoprotective effects of virgin avocado oil in diet-induced hypercholesterolaemia rats
by: Tan, Chin Xuan, et al.
Published: (2018)
by: Tan, Chin Xuan, et al.
Published: (2018)
Stabilized sparse ordinal regression for medical risk stratification
by: Tran, The Truyen, et al.
Published: (2014)
by: Tran, The Truyen, et al.
Published: (2014)
The impact of stratifying by family history in colorectal cancer screening programs
by: Goede, S., et al.
Published: (2015)
by: Goede, S., et al.
Published: (2015)
Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing
by: Maxwell, S., et al.
Published: (2017)
by: Maxwell, S., et al.
Published: (2017)
The potential impact of NIPT as a second-tier screen on the outcomes of high-risk pregnancies with rare chromosomal abnormalities
by: Maxwell, S., et al.
Published: (2015)
by: Maxwell, S., et al.
Published: (2015)
Similar Items
-
Parent-child genetic testing for familial hypercholesterolaemia in an Australian context
by: Pang, J., et al.
Published: (2018) -
A new model of care for familial hypercholesterolaemia from Western Australia: closing a major gap in preventive cardiology
by: Watts, G., et al.
Published: (2010) -
Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
by: Ademi, Z., et al.
Published: (2014) -
Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations
by: Watts, G., et al.
Published: (2012) -
A web-based registry for familial hypercholesterolaemia
by: Napier, K., et al.
Published: (2017)